Edwards Lifesciences (EW) Net Income towards Common Stockholders Growth (1y) (2010 - 2026)
Powered by 
Analysis
Edwards Lifesciences (EW) Net Income towards Common Stockholders Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.67 Bn | 178.06 Bn | 7.27 Bn | -47.84% |
| 2 | Intuitive Surgical | 124.18 Bn | 118.97 Bn | 1.96 Bn | 23.94% |
| 3 | Medtronic | 118.33 Bn | 109.51 Bn | 6.34 Bn | 41.36% |
| 4 | Stryker | 105.21 Bn | 101.73 Bn | 4.50 Bn | 44.34% |
| 5 | Boston Scientific | 66.61 Bn | 66.07 Bn | 3.85 Bn | 13.80% |
| 6 | Edwards Lifesciences | 49.73 Bn | 45.47 Bn | 1.35 Bn | -27.18% |
| 7 | Alcon | 33.91 Bn | 32.46 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.28 Bn | 30.34 Bn | 830.00 Mn | 38.54% |
| 9 | Steris | 21.09 Bn | 20.61 Bn | 684.20 Mn | 12.92% |
| 10 | Zimmer Biomet Holdings | 18.18 Bn | 17.77 Bn | 1.54 Bn | 30.12% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -27.18% |
| Mar 31, 2026 | 6.82% |
| Dec 31, 2025 | -76.27% |
| Sep 30, 2025 | -90.54% |
| Jun 30, 2025 | -9.18% |
| Mar 31, 2025 | 1.54% |
| Dec 31, 2024 | 3.95% |
| Sep 30, 2024 | 699.95% |
| Jun 30, 2024 | 18.39% |
| Mar 31, 2024 | 3.08% |
| Dec 31, 2023 | -7.20% |
| Sep 30, 2023 | 11.70% |
| Jun 30, 2023 | -24.14% |
| Mar 31, 2023 | -8.86% |
| Dec 31, 2022 | 18.82% |
| Sep 30, 2022 | 1.00% |
| Jun 30, 2022 | -16.98% |
| Mar 31, 2022 | 10.47% |
| Dec 31, 2021 | 8.34% |
| Sep 30, 2021 | 4.58% |